FDA Accepts Arcutis’ Supplemental New Drug Application for Roflumilast[...]
Pasithea Therapeutics Corporation
Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for[...]
10X Capital Venture Acquisition II[...]
10X Capital Venture Acquisition Corp. II Announces New Date for[...]
10/03/2023 | Press release | Distributed by Public on 10/03/2023 15:20
Please select the service you want to use:
Copyright ©2006-2023 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact